<?xml version="1.0" encoding="UTF-8"?>
<p>Female patients with breast cancer aged 40 to 60 years old with pathologically confirmed breast cancer patients who met the CLINICAL practice guidelines for NCCN breast cancer (2018.v1); KPS score no less than 60 points, WBC no less than 4.0 × 10
 <sup>9</sup> before treatment, normal liver and renal function, expected survival above three months; All were pathologically confirmed breast cancer patients who met the CLINICAL practice guidelines for NCCN breast cancer (2018.v1) after modified radical mastectomy and received chemotherapy with AC regimen (adriamycin + cyclophosphamide) or TAC regimen (docetaxel + adriamycin + cyclophosphamide) for the first time. All the selected patients have signed informed consent and are willing to accept the treatment of this program.
</p>
